Abcam
ABCM · — · Biotech
Abcam Limited is a producer, distributor and seller of protein research tools operating worldwide from 13 locations with 1,800 employees of which 400 work in Research and Development (R&D). Abcam was listed on the Nasdaq and the London Stock Exchange until it was acquired by Danaher Corporation in 2023.
Current Price
$23.99
Market Cap
$5.5B
Return Since Last Split
—
Last Split
Dec 1, 2010
Total Splits
1
Cumulative Multiple
5×
What If You Bought ABCM Earlier?
Investment
Purchase Date (Before Split)
Worth Today
$11,995
500 shares · 5×
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth from that date to today.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Dec 1, 2010 | — | 5-for-1 | 5× | 5× |
Abcam Market Cap Timeline
Validated annual market-cap history is available from 2012. Split markers cover all 1 recorded split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.
Frequently Asked Questions
Abcam's latest record in the split calendar is a 5-for-1 forward split effective 2010-12-01.